{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:31:54Z","timestamp":1785497514547,"version":"3.56.0"},"reference-count":47,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/13696998.2023.2248840","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T14:32:47Z","timestamp":1693060367000},"page":"1061-1071","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Transarterial therapies in patients with hepatocellular carcinoma eligible for transarterial embolization: a US cost-effectiveness analysis"],"prefix":"10.1080","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8715-2063","authenticated-orcid":false,"given":"Mikin V.","family":"Patel","sequence":"first","affiliation":[{"name":"Section of Interventional Radiology, Department of Radiology, University of Chicago Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1943-3765","authenticated-orcid":false,"given":"Heather","family":"Davies","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium, University of York, Heslington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1982-8417","authenticated-orcid":false,"given":"Abimbola O.","family":"Williams","sequence":"additional","affiliation":[{"name":"Boston Scientific, Marlborough, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2494-5685","authenticated-orcid":false,"given":"Tom","family":"Bromilow","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium, University of York, Heslington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Baker","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium, University of York, Heslington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2564-1440","authenticated-orcid":false,"given":"Stuart","family":"Mealing","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium, University of York, Heslington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2559-061X","authenticated-orcid":false,"given":"Hayden","family":"Holmes","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium, University of York, Heslington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Anderson","sequence":"additional","affiliation":[{"name":"Boston Scientific, Marlborough, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Section of Interventional Radiology, Department of Radiology, University of Chicago Medicine, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,8,26]]},"reference":[{"key":"e_1_3_9_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29855"},{"key":"e_1_3_9_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/op.21.00227"},{"key":"e_1_3_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.018"},{"key":"e_1_3_9_5_1","doi-asserted-by":"publisher","DOI":"10.15761\/gos.1000171"},{"key":"e_1_3_9_6_1","unstructured":"Food and Drink Administration. Recently approved devices: therasphere \u2013 P200029. 2021. Available from: https:\/\/www.fda.gov\/medical-devices\/recently-approved-devices\/theraspheretm-p200029."},{"key":"e_1_3_9_7_1","doi-asserted-by":"publisher","DOI":"10.2147\/jhc.S335879"},{"key":"e_1_3_9_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.08.029"},{"key":"e_1_3_9_9_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.211806"},{"key":"e_1_3_9_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31819"},{"key":"e_1_3_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02695.x"},{"key":"e_1_3_9_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31318"},{"key":"e_1_3_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.08.027"},{"key":"e_1_3_9_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7491.597"},{"key":"e_1_3_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2014.04.014"},{"key":"e_1_3_9_16_1","unstructured":"National Liver Review Board (NLRB). Guidance to liver transplant programs and the national liver review board for: adult MELD exceptions for hepatocellular carcinoma (HCC). 2022."},{"key":"e_1_3_9_17_1","doi-asserted-by":"publisher","DOI":"10.2147\/jhc.S248314"},{"key":"e_1_3_9_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.12195"},{"key":"e_1_3_9_19_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018171768"},{"key":"e_1_3_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2016.02.005"},{"key":"e_1_3_9_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.199"},{"key":"e_1_3_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/hpb.12300"},{"key":"e_1_3_9_23_1","volume-title":"Lenvatinib for advanced, unresectable, untreated hepatocellular carcinoma [ID1089]","author":"National Institute for Health and Care Excellence","year":"2018","unstructured":"National Institute for Health and Care Excellence. Lenvatinib for advanced, unresectable, untreated hepatocellular carcinoma [ID1089]. London: National Institute for Health and Care Excellence; 2018."},{"key":"e_1_3_9_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27135"},{"key":"e_1_3_9_25_1","unstructured":"York Health Economics Consortium. Utility. 2016. Available from: https:\/\/yhec.co.uk\/glossary\/utility\/."},{"key":"e_1_3_9_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-020-02650-y"},{"key":"e_1_3_9_27_1","unstructured":"UNOS. OPTN Metrics (Liver): UNOS. 2021 [cited 2021 Oct]. Available from: https:\/\/insights.unos.org\/OPTN-metrics\/."},{"key":"e_1_3_9_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857"},{"key":"e_1_3_9_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-008-0652-2"},{"key":"e_1_3_9_30_1","volume-title":"2020\u2009U.S. organ and tissue transplants: cost estimates, discussion, and emerging issues","author":"Bentley TS","year":"2020","unstructured":"Bentley TS, Ortner N. 2020\u2009U.S. organ and tissue transplants: cost estimates, discussion, and emerging issues. Milliman Research Report; Seattle, WA; 2020."},{"issue":"7","key":"e_1_3_9_31_1","first-page":"1","article-title":"Tables, 2017. National vital statistics reports: from the centers for disease control and prevention, national center for health statistics","volume":"68","author":"Arias E. United States Life","year":"2019","unstructured":"Arias E. United States Life. Tables, 2017. National vital statistics reports: from the centers for disease control and prevention, national center for health statistics. Natl Vital Stat Sys. 2019;68(7):1\u201366.","journal-title":"Natl Vital Stat Sys"},{"key":"e_1_3_9_32_1","unstructured":"Centers for Medicare & Medicaid Services. Healthcare cost report information system. 2020 [cited 2021 June]. Available from: https:\/\/www.cms.gov\/."},{"key":"e_1_3_9_33_1","unstructured":"IBM. IBM Micromedex RED BOOK. Colorado: IBM. 2021 [cited 2021 March]. Available from: https:\/\/www.ibm.com\/uk-en\/products\/micromedex-red-book."},{"key":"e_1_3_9_34_1","unstructured":"U.S. Bureau of Labor Statistics. CPI inflation calculator. 2021 [cited 2021 June]. Available from: https:\/\/www.bls.gov\/data\/inflation_calculator.htm."},{"key":"e_1_3_9_35_1","unstructured":"Sermo. 2022 [cited 2022 Jan 18]. Available from: https:\/\/www.sermo.com\/."},{"key":"e_1_3_9_36_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta24480"},{"key":"e_1_3_9_37_1","unstructured":"York Health Economics Consortium. Quality-adjusted life year. 2016. Available from: https:\/\/yhec.co.uk\/glossary\/quality-adjusted-life-year-qaly\/."},{"key":"e_1_3_9_38_1","unstructured":"York Health Economics Consortium. Incremental cost-effectiveness ratio. 2016. Available from: https:\/\/yhec.co.uk\/glossary\/incremental-cost-effectiveness-ratio-icer\/."},{"key":"e_1_3_9_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1405158"},{"key":"e_1_3_9_40_1","first-page":"609","volume-title":"Clin Cancer Res","author":"American Association for Cancer Research","year":"2022","unstructured":"American Association for Cancer Research. AACR report on the impact of COVID-19 on cancer research and patient care. Clin Cancer Res. 2022;28(4):609\u2013610."},{"key":"e_1_3_9_41_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-1004"},{"key":"e_1_3_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.09.2397"},{"key":"e_1_3_9_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/OP.20.00443"},{"key":"e_1_3_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2011.11.016"},{"key":"e_1_3_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.11.1351"},{"key":"e_1_3_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)30207-1"},{"key":"e_1_3_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(20)30290-9"},{"key":"e_1_3_9_48_1","doi-asserted-by":"publisher","DOI":"10.5009\/gnl.2010.4.S1.S113"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2023.2248840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T09:59:51Z","timestamp":1701943191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2023.2248840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,26]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/13696998.2023.2248840"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2023.2248840","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}